News & Perspective

Jan 11, 2016

Jan 11, 2016
Nasal spray flu vaccine

Studies note nasal spray vaccine failure against H1N1 flu

The initial effectiveness investigations flagged a problem with the 2009 H1N1 vaccine virus in the inhaled version and drove improvement efforts.

Feb 01, 2013

Feb 01, 2013

CDC: Pandemic vaccine prevented 1 million cases, 300 deaths

(CIDRAP News) – The influenza vaccine that was developed to fight the 2009 pandemic saved roughly 300 lives and prevented about 1 million illnesses and 6,000 hospitalizations, or under 3% of the estimated total burden in each category, according to new estimates from the Centers for Disease Control and Prevention (CDC).

Oct 15, 2012

Oct 15, 2012

Report: Complacency, misperception stymie quest for better flu vaccines

The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.

Jul 11, 2012

Jul 11, 2012

Study flags drop in antivirals for hospitalized flu patients

(CIDRAP News) – Researchers following recent antiviral trends in the United States have found a troubling drop in the use of the drugs for treating hospitalized patients with lab-confirmed flu, especially children.

Oct 29, 2010

Oct 29, 2010

IOM report airs lessons of H1N1 vaccination campaign

(CIDRAP News) – A workshop summary released today by the Institute of Medicine (IOM) offers a wide range of observations and suggestions about what worked well and not so well during the pandemic H1N1 influenza vaccination campaign—a complex, months-long operation with a cast of thousands.

Sep 20, 2010

Sep 20, 2010

CDC finalizes flu prevention guidance for health settings

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) recently issued new guidance for preventing flu in healthcare settings that reflects a year's worth of new information about the 2009 H1N1 virus and recommends surgical masks rather than N-95 respirators when providing routine care for flu patients.

Aug 06, 2010

Aug 06, 2010

Shelf life for remaining H1N1 vaccine to be shortened

(CIDRAP News) – About 16 million remaining doses of monovalent 2009 H1N1 vaccine made by Sanofi Pasteur and packaged in multidose vials will expire sooner than expected, but expiration dates have not yet been determined, federal health officials and the company said today.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»